Alkem Laboratories Limited (NSE:ALKEM)
India
· Delayed Price · Currency is INR | Market Cap | 674.29B |
| Revenue (ttm) | 142.53B |
| Net Income (ttm) | 23.71B |
| Shares Out | 119.57M |
| EPS (ttm) | 198.31 |
| PE Ratio | 28.44 |
| Forward PE | 28.77 |
| Dividend | 45.00 (0.80%) |
| Ex-Dividend Date | Feb 20, 2026 |
| Volume | 131,566 |
| Average Volume | 143,287 |
| Open | 5,752.00 |
| Previous Close | 5,752.00 |
| Day's Range | 5,614.00 - 5,781.50 |
| 52-Week Range | 4,491.65 - 5,933.50 |
| Beta | 0.30 |
| RSI | 51.36 |
| Earnings Date | Feb 13, 2026 |
About Alkem Laboratories
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, r... [Read more]
Financial Performance
In fiscal year 2025, Alkem Laboratories's revenue was 129.65 billion, an increase of 2.34% compared to the previous year's 126.68 billion. Earnings were 21.65 billion, an increase of 20.59%.
Financial StatementsNews
Stocks to buy today, Feb 17: Eicher Motors, Alkem Labs, JK Cement, Tata Steel, Hitachi Energy, LIC Housing Finance, Coforge among brokerage recommendations
Several brokerages have reiterated bullish calls on select large-cap and mid-cap stocks, maintaining positive ratings with revised target prices. Goldman...
Esperion (ESPR) Settles Patent Dispute with Alkem Laboratories
Esperion (ESPR) Settles Patent Dispute with Alkem Laboratories
Top stocks to watch today, Feb 17: Cochin Shipyard, Lupin, Alkem Laboratories, Texmaco Rail and more
Indian equity markets are expected to track stock-specific developments on February 17, with several companies announcing order wins, partnerships, stake...
Alkem Laboratories Ltd (BOM:539523) Q3 2026 Earnings Call Highlights: Strong International ...
Alkem Laboratories Ltd (BOM:539523) Q3 2026 Earnings Call Highlights: Strong International Sales Drive Revenue Growth Amid Profitability Challenges
Q3 2026 Alkem Laboratories Ltd Earnings Call Transcript
Q3 2026 Alkem Laboratories Ltd Earnings Call Transcript
Alkem Laboratories board declares interim dividend of Rs 43 per share for FY26
Alkem Laboratories has announced an interim dividend of ₹43 per equity share with a face value of ₹2 each for...
Alkem Laboratories Q3 Results: Revenue jumps 10.7% YoY to Rs 3,736.82 crore, net profit up 1.9%
Alkem Laboratories reported steady growth in its December 2025 quarter (Q3FY26), with revenue and operating profit improving on a year-on-year...
Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Reports Q3 2026 Result
Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Reports Q3 2026 Result
Alkem Laboratories receives GST demand order of Rs 2.35 crore; company plans appeal
Shares of Alkem Laboratories were in focus after the company disclosed that it has received a demand order from the...
Stocks to buy: What's the outlook for Nifty for the week starting January 12, 2026? Check list of top stock recommendations
Stock market recommendations: Sudeep Shah of SBI Securities recommends Alkem Laboratories, and MTAR Technologies as his top stock picks for this week. Here’s his outlook on Nifty, Bank Nifty:
Alkem Laboratories’ Daman facility clears Malta GMP inspection with no critical observations
Alkem Laboratories has recently informed exchanges that the Malta Medicines Authority conducted a Good Manufacturing Practices (GMP) inspection at the...
Top stocks to watch today, November 21: TCS, Godrej Properties, JSW Energy, Hyundai Motor India, Alkem Laboratories and more
Indian equities are set for an active start on November 21, 2025, as several companies issued regulatory filings, business updates,...
Alkem Laboratories launches De Simone formulation probiotic ‘DSS’ in India
Alkem Laboratories Ltd. has introduced the DSS probiotic range in India, bringing the globally acclaimed De Simone formulation to the...
Jubilant Foodworks, Voltas & more: Top stocks on brokers' radar today
CLSA downgraded Jubilant Foodworks to underperform, citing missed sales estimates. Jefferies maintained a buy on Voltas despite Q2 misses, while Bernstein upgraded Muthoot Finance to outperform on str...
Nomura bullish on Alkem Labs as company lifts US growth guidance to double digits
Nomura has reiterated its buy rating on Alkem Laboratories with a target price of ₹6,860 per share after the company...
Alkem Labs share price: Nomura maintains buy with Rs 6,860 target price, says broad-based growth to continue
Nomura has reiterated its buy rating on Alkem Laboratories with a target price of ₹6,860 per share after the company...
HSBC raises target price for Alkem Labs following better than expected Q2 results
HSBC has maintained its hold rating on Alkem Laboratories while raising the target price to ₹5,170 per share following a...
Alkem Laboratories Ltd (BOM:539523) Q2 2026 Earnings Call Highlights: Record Revenue and ...
Alkem Laboratories Ltd (BOM:539523) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Operational Challenges
Q2 2026 Alkem Laboratories Ltd Earnings Call Transcript
Q2 2026 Alkem Laboratories Ltd Earnings Call Transcript
Alkem Laboratories Q2 Results: Revenue jumps 17.2% YoY to Rs 4,001 crore, net profit up 11.1%
Alkem Laboratories has reported a solid year-on-year performance for the September quarter, reflecting consistent demand across key therapeutic areas and...
Alkem Foundation partners with IIT Bombay to set up India’s first advanced immuno-therapeutics & regenerative medicine research centre
Alkem Foundation, the CSR arm of Alkem Laboratories Ltd, has announced a strategic collaboration with the Indian Institute of Technology...
Alkem Laboratories transfers trade generics business to subsidiary Alkem Wellness, effective October 1
Alkem Laboratories Limited announced on Friday, September 26, that it has formally entered into a Business Transfer Agreement with its wholly owned subsidiary, Alkem Wellness Limited, for the transfer...
Alkem Laboratories launches pertuza biosimilar for treatment of HER2-positive breast cancer
Alkem Laboratories has announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer. Developed and manufactured indigenously...
Stocks to watch on August 22: Key brokerage calls on cement, GMR Airports, Wipro, autos, Alkem Labs, Reliance, and HAL
Indian equities are set to trade with stock-specific action on Friday, August 22, as global brokerage commentary highlights opportunities across cement, airports, IT, autos, pharma, and defence. Analy...
Nomura raises target price on Alkem Labs, says valuation attractive on domestic growth and Enzene prospects
Nomura has maintained its buy rating on Alkem Laboratories and raised the target price to ₹6,300, citing a recovery in domestic growth and strong prospects for its subsidiary Enzene as key drivers. Th...